Share This Article:

Oral Propranolol: A Useful Treatment for Infantile Hemangioma

Abstract Full-Text HTML XML Download Download as PDF (Size:2655KB) PP. 441-450
DOI: 10.4236/jbise.2015.87041    2,941 Downloads   3,632 Views   Citations

ABSTRACT

Background: Infantile haemangioma is the commonest childhood tumor. Several lines of treatment are available. Recent reports have focused on the value of propranolol in treating rapidly proliferating haemangioma. The aim of this study was to assess oral propranolol in treatment for facial haemangioma. Patients and Methods: Fifteen patients with rapidly proliferating infantile facial haemangioma with cosmetic disfigurement were treated with oral propranolol. All patients had cardiovascular pre-treatment work-up and commenced on oral propranolol at 3 mg/kg/day. Results: A rapid decrease in hemangioma proliferation was seen in 100% of patients and significant regressions occuring in all patients. This treatment was well tolerated and had little side effects. Conclusions: Oral propranolol is a reliable and easily reproducible method for treatment of facial hemangioma.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

El-Sabbagh, A. (2015) Oral Propranolol: A Useful Treatment for Infantile Hemangioma. Journal of Biomedical Science and Engineering, 8, 441-450. doi: 10.4236/jbise.2015.87041.

References

[1] Mulliken, J.B. (2008) Color Atlas of Vascular Tumors and Vascular Malformations. Plastic and Reconstructive Surgery, 121, 333.
http://dx.doi.org/10.1097/01.prs.0000302375.97376.7f
[2] Kilcline, C. and Frieden, I.J. (2008) Infantile Hemangiomas: How Common Are They? A Systematic Review of the Medical Literature. Pediatric Dermatology, 25, 168-173.
http://dx.doi.org/10.1111/j.1525-1470.2008.00626.x
[3] Itinteang, T., Tan, S.T., Brasch, H. and Day, D.J. (2010) Primitive Mesodermal Cells with a Neural Crest Stem Cell Phenotype Predominate Proliferating Infantile Haemangioma. Journal of Clinical Pathology, 63, 771-776.
http://dx.doi.org/10.1136/jcp.2010.079368
[4] Itinteang, T., Brasch, H.D., Tan, S.T. and Day, D.J. (2011) Expression of Components of the Renin-Angiotensin System in Proliferating Infantile Haemangioma May Account for the Propranolol-Induced Accelerated Involution. Journal of Plastic, Reconstructive & Aesthetic Surgery, 64, 759-765.
http://dx.doi.org/10.1016/j.bjps.2010.08.039
[5] Mohamed, A.M., Elwakil, T.F., Taher, I.M., Elbarbary, M.M., Kayed, H.F., Hussein, H.A. and Eid, O.M. (2009) Cyclin D1 Gene Amplification in Proliferating Haeman-gioma. Cell and Tissue Research, 338, 107-115.
http://dx.doi.org/10.1007/s00441-009-0858-y
[6] Walter, J.W., North, P.E., Waner, M., Mizeracki, A., Blei, F., Walker, J.W., Reinisch, J.F. and Marchuk, D.A. (2002) Somatic Mutation of Vascular Endothelial Growth Factor Receptors in Juvenile Haemangioma. Genes Chromosomes Cancer, 33, 295-303.
http://dx.doi.org/10.1002/gcc.10028
[7] Yu, Y., Fuhr, J., Boye, E., Gyorffy, S., Soker, S., Atala, A., Mulliken, J.B. and Bischoff, J. (2006) Mesenchymal Stem Cells and Adipogenesis in Hemangioma Involution. Stem Cells, 24, 1605-1612.
http://dx.doi.org/10.1634/stemcells.2005-0298
[8] Chang, L.C., Haggstrom, A.N., Drolet, B.A., Baselga, E., Chamlin, S.L., Garzon, M.C., Horii, K.A., Lucky, A.W., Mancini, A.J., Metry, D.W., Nopper, A.J., Frieden, I.J., et al. (2008) Growth Characteristics of Infantile Hemangiomas: Implications for Management. Pediatrics, 122, 360-367.
http://dx.doi.org/10.1542/peds.2007-2767
[9] Drolet, B.A., Esterly, N.B. and Frieden, I.J. (1999) Hemangiomas in Children. The New England Journal of Medicine, 341, 173-181.
http://dx.doi.org/10.1056/NEJM199907153410307
[10] Fawcett, S.L., Grant, I., Hall, P.N., Kelsall, A.W. and Nicholson, J.C. (2004) Vincristine as a Treatment for a Large Haemangioma Threatening Vital Functions. Brazilian Journal of Probability and Statistics, 57, 168-171.
[11] Batniji, R.K., Buckingham, E.D. and Williams, E.F. (2005) An Aesthetic Approach to Facial Hemangiomas. Archives of Facial Plastic Surgery, 7, 301-306.
http://dx.doi.org/10.1001/archfaci.7.5.301
[12] Williams, E.F., Stanislaw, P., Dupree, M., Mourtzikos, K., Mihm, M. and Shannon, L. (2000) Hemangiomas in Infants and Children: An Algorithm for Intervention. Archives of Facial Plastic Surgery, 2, 103-111.
http://dx.doi.org/10.1001/archfaci.2.2.103
[13] Leaute-Labreze, C., Dumas de la Roque, E., Hubiche, T., Boralevi, F., Thambo, J.B. and Taieb, A. (2008) Propranolol for Severe Hemangiomas of Infancy. New England Journal of Medicine, 358, 2649-2651.
http://dx.doi.org/10.1056/NEJMc0708819
[14] Michel, J.L. and Patural, H. (2009) Response to Oral Propranolol Therapy for Ulcerated Hemangiomas in Infancy. Archives de Pédiatrie, 16, 1565-1568.
http://dx.doi.org/10.1016/j.arcped.2009.09.008
[15] Gruber, R.P., Roberts, C., Schooler, W. and Pitman, R.K. (2009) Preventing Postsurgical Dissatisfaction Syndrome after Rhinoplasty with Propranolol: A Pilot Study. Plastic and Reconstructive Surgery, 123, 1072-1078.
http://dx.doi.org/10.1097/PRS.0b013e318199f63f
[16] Romana-Souza, B., Nascimento, A.P. and Monte-Alto-Costa, A. (2008) Low-Dose Propranolol Improves Cutaneous Wound Healing of Burn-Injured Rats. Plastic and Reconstructive Surgery, 122, 1690-1699.
http://dx.doi.org/10.1097/PRS.0b013e31818cbf67
[17] Storch, C.H. and Hoeger, P.H. (2010) Propranolol for Infantile Haemangiomas: Insights into the Molecular Mechanisms of Action. British Journal of Dermatology, 163, 269-274.
http://dx.doi.org/10.1111/j.1365-2133.2010.09848.x
[18] Tan, S.T., Itinteang, T. and Leadbitter, P. (2010) Low-Dose Propranolol for Infantile Haemangioma. Journal of Plastic, Reconstructive & Aesthetic Surgery, 64, 292-299.
http://dx.doi.org/10.1016/j.bjps.2010.06.010
[19] Holmes, W.J., Mishra, A., Gorst, C. and Liew, S.H. (2011) Propranolol as First-Line Treatment for Rapidly Proliferating Infantile Haemangiomas. Journal of Plastic, Reconstructive & Aesthetic Surgery, 64, 445-451.
http://dx.doi.org/10.1016/j.bjps.2010.07.009
[20] Talaat, A.A., Elbasiouny, M.S., Elgendy, D.S. and Elwakil, T.F. (2012) Propranolol Treatment of Infantile Hemangioma: Clinical and Radiologic Evaluations. Journal of Pediatric Surgery, 47, 707-714.
http://dx.doi.org/10.1016/j.jpedsurg.2011.10.058
[21] Greene, A.K. (2011) Management of Hemangiomas and Other Vascular Tumors. Clinics in Plastic Surgery, 38, 45-63.
http://dx.doi.org/10.1016/j.cps.2010.08.001
[22] Boon, L.M., MacDonald, D.M. and Mulliken, J.B. (1999) Complications of Systemic Corticosteroid Therapy for Problematic Hemangioma. Plastic and Reconstructive Surgery, 104, 1616-1623.
http://dx.doi.org/10.1097/00006534-199911000-00002
[23] Spector, J.A., Blei, F. and Zide, B.M. (2008) Early Surgical Intervention for Proliferating Hemangiomas of the Scalp: Indications and Outcomes. Plastic and Reconstructive Surgery, 122, 457-462.
http://dx.doi.org/10.1097/PRS.0b013e31817d5fa2
[24] Hamou, C., Diner, P.A., Dalmonte, P., Vercellino, N., Soupre, V., Enjolras, O., Vazquez, M.P. and Picard, A. (2010) Nasal Tip Haemangiomas: Guidelines for an Early Surgical Approach. Journal of Plastic, Reconstructive & Aesthetic Surgery, 63, 934-939.
http://dx.doi.org/10.1016/j.bjps.2009.05.020
[25] Chang, C.S., Wong, A., Rohde, C.H., Ascherman, J.A. and Wu, J.K. (2012) Management of Lip Haemangiomas: Minimizing Peri-Oral Scars. Journal of Plastic, Reconstructive & Aesthetic Surgery, 65, 163-168.
http://dx.doi.org/10.1016/j.bjps.2011.08.033
[26] Lawley, L.P., Siegfried, E. and Todd, J.L. (2009) Propranolol Treatment for Hemangioma of Infancy: Risks and Recommendations. Pediatric Dermatology, 26, 610-614.
http://dx.doi.org/10.1111/j.1525-1470.2009.00975.x
[27] Metz, B.J., Rubenstein, M.C., Levy, M.L. and Metry, D.W. (2004) Response of Ulcerated Perineal Hemangiomas of Infancy to Becaplermin Gel, a Recombinant Human Platelet-Derived Growth Factor. Archives of Dermatology, 140, 867-870.
http://dx.doi.org/10.1001/archderm.140.7.867
[28] Chamlin, S.L., Haggstrom, A.N., Drolet, B.A., Baselga, E., Frieden, I.J., Garzon, M.C., Horii, K.A., Lucky, A.W., Metry, D.W., Newell, B., Nopper, A.J. and Mancini, A.J. (2007) Multicenter Prospective Study of Ulcerated Hemangiomas. The Journal of Pediatrics, 151, 684-689.
[29] Sans, V., de la Roque, E.D., Berge, J., Grenier, N., Boralevi, F., Mazereeuw-Hautier, J., Lipsker, D., Dupuis, E., Ezzedine, K., Vergnes, P., Taieb, A. and Léauté-Labrèze, C. (2009) Propranolol for Severe Infantile Hemangiomas: Follow-Up Report. PEDIATRICS, 124, e423-e431.
http://dx.doi.org/10.1542/peds.2008-3458
[30] Naouri, M., Schill, T., Maruani, A., Bross, F., Lorette, G. and Rossler, J. (2010) Successful Treatment of Ulcerated Haemangioma with Propranolol. Journal of the European Academy of Dermatology and Venereology, 24, 1109-1112.
[31] Itinteang, T., Withers, A.H., Leadbitter, P., Day, D.J. and Tan, S.T. (2011) Pharmacologic Therapies for Infantile Hemangioma: Is There a Rational Basis? Plastic and Reconstructive Surgery, 128, 499-507.
http://dx.doi.org/10.1097/PRS.0b013e31821b63a0

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.